Vivian W. Y. Wong

PhD-trained scientist with over a decade of experience in therapeutic antibody discovery and biologics R&D across biotech and pharma. My work spans early discovery through to IND-enabling studies, with a strong track record in advancing antibody programmes and leading multidisciplinary teams. I am the co-founder of MabGalaxy, a Cambridge-based biotech start-up developing AI-enabled antibody therapeutics for inflammatory diseases. We are currently part of the Accelerate@Babraham 2025 cohort, advancing our platform and early R&D programmes. I’m driven by the challenge of translating scientific ideas into real-world therapies and by building collaborative teams with a shared sense of purpose. As we grow MabGalaxy, I’m open to connecting with fellow founders, investors, scientific collaborators, and others interested in advancing innovation in antibody drug discovery.